VAM
PACB icon

Visium Asset Management’s Pacific Biosciences PACB Stock Holding History

Visium Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-39,659
Closed -$279K – 146
2016
Q2 		$279K Buy
+39,659
New +$362K 0.02% 297
2015
Q3 		– Sell
-10,300
Closed -$59K – 1115
2015
Q2 		$59K Buy
+10,300
New +$59.6K ﹤0.01% 1073
2013
Q4 		– Sell
-20,000
Closed -$111K – 952
2013
Q3 		$111K Sell
20,000
-994,000
-98% -$3.45M ﹤0.01% 731
2013
Q2 		$2.56M Buy
+1,014,000
New +$2.52M 0.06% 201

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return